Finance

Lists
CORONA:NSE
Corona Remedies Ltd
₹2,053.00
-1.27%
(-26.50) 1D
Aug 31, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for CORONA...
Open
₹2,075.00
High
₹2,075.00
Low
₹2,041.00
Mkt. cap
125.10B
Avg. vol.
0.00
Volume
9.58K
Dividend
0.49%
Quarterly dividend
₹2.50
Ex-dividend date
Jun 19, 2026
P/E ratio
63.10
52-wk high
₹2,270.10
52-wk low
₹1,336.60
EPS
₹32.54
No. of employees
5K
Open
₹2,075.00
High
₹2,075.00
Low
₹2,041.00
Mkt. cap
125.10B
Avg. vol.
0.00
Volume
9.58K
Dividend
0.49%
Quarterly dividend
₹2.50
Ex-dividend date
Jun 19, 2026
P/E ratio
63.10
52-wk high
₹2,270.10
52-wk low
₹1,336.60
EPS
₹32.54
No. of employees
5K
About Corona Remedies Ltd
CEO-
Employees5.15K
Founded2004
Headquarters-
SectorPharmaceutical industry
Websitecoronaremedies.com
Last report
Jul 31, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹9.83 / ₹9.20
+6.85%beat
Revenue / Est. (INR)
4.22B / 4.04B
+4.64%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.61B
3.42B
3.53B
4.22B
Cost of goods sold
686.50M
602.70M
772.40M
775.20M
Cost of revenue
686.50M
602.70M
772.40M
775.20M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.03B
959.40M
2.14B
1.22B
Operating expense
2.23B
2.08B
2.24B
2.65B
Total operating expenses
2.92B
2.69B
3.01B
3.43B
Operating income
692.70M
737.10M
522.70M
798.90M
Other non operating income
22.70M
22.40M
-58.90M
31.50M
EBT including unusual items
697.80M
552.10M
547.40M
803.60M
EBT excluding unusual items
697.80M
743.10M
550.20M
803.60M
Income tax expense
174.60M
139.40M
94.10M
202.50M
Effective tax rate
25.02%
25.25%
17.19%
25.20%
Other operating expenses
1.11B
1.03B
-7.00M
1.30B
Net income
523.20M
412.70M
453.30M
601.10M
Net profit margin
14.49%
12.05%
12.84%
14.23%
Earnings per share
-
-
7.41
9.83
Interest and investment income
-
-
70.60M
-
Interest expense
-19.30M
-16.60M
-11.10M
-26.90M
Net interest expenses
-19.30M
-16.60M
59.50M
-26.90M
Depreciation and amortization charges
92.00M
94.50M
102.90M
132.40M
EBITDA
794.16M
838.56M
608.10M
884.30M
Gain or loss from assets sale
2.61M
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps